According to the annual report there were two objections to the patent extension in June - any idea what these were and what response was submitted to these objections.
What is the chance of not overcoming these objections? Acrux say they are confident but of course they would.
The thing on their side is that it has already been approved in other countries.
Add to My Watchlist
What is My Watchlist?
